1 Cash-Heavy Stock to Research Further and 2 Facing Headwinds

1 Cash-Heavy Stock to Research Further and 2 Facing Headwinds

Kayode Omotosho

Mon, February 16, 2026 at 1:46 PM GMT+9 3 min read

In this article:

NATR

+1.55%

FRSH

+2.84%

PGNY

-1.38%

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Not all businesses with cash are winners, and that’s why we built StockStory - to help you separate the good from the bad. Keeping that in mind, here is one company with a net cash position that can leverage its balance sheet to grow and two with hidden risks.

Two Stocks to Sell:

Nature’s Sunshine (NATR)

Net Cash Position: $81.27 million (17.3% of Market Cap)

Started on a kitchen table in Utah, Nature’s Sunshine (NASDAQ:NATR) manufactures and sells nutritional and personal care products.

Why Does NATR Give Us Pause?

Lackluster 2.8% annual revenue growth over the last three years indicates the company is losing ground to competitors

Subscale operations are evident in its revenue base of $474.5 million, meaning it has fewer distribution channels than its larger rivals

Projected sales growth of 3.1% for the next 12 months suggests sluggish demand

Nature’s Sunshine is trading at $25.88 per share, or 28.6x forward P/E. Check out our free in-depth research report to learn more about why NATR doesn’t pass our bar.

Progyny (PGNY)

Net Cash Position: $317.1 million (17.8% of Market Cap)

Pioneering a data-driven approach to family building that has achieved an industry-leading patient satisfaction score of +80, Progyny (NASDAQ:PGNY) provides comprehensive fertility and family building benefits solutions to employers, helping employees access quality fertility treatments and support services.

Why Is PGNY Not Exciting?

Smaller revenue base of $1.27 billion means it hasn’t achieved the economies of scale that some industry juggernauts enjoy

ROIC of 4% reflects management’s challenges in identifying attractive investment opportunities

Progyny’s stock price of $20.81 implies a valuation ratio of 11.1x forward P/E. To fully understand why you should be careful with PGNY, check out our full research report (it’s free).

One Stock to Watch:

Freshworks (FRSH)

Net Cash Position: $810.5 million (39.7% of Market Cap)

Starting as a customer service solution before expanding into a comprehensive software suite, Freshworks (NASDAQ:FRSH) provides AI-powered software-as-a-service solutions that help companies manage customer service, IT support, sales, and marketing functions.

Why Are We Fans of FRSH?

ARR growth averaged 17.8% over the last year, showing customers are willing to take multi-year bets on its software

Software is difficult to replicate at scale and leads to a top-tier gross margin of 85%

Operating profits and efficiency rose over the last year as it benefited from some fixed cost leverage

 






繼續閱讀  

At $7.26 per share, Freshworks trades at 2.1x forward price-to-sales. Is now a good time to buy? See for yourself in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

條款 及 私隱政策

Privacy Dashboard

More Info